BloggingStocks http://www.bloggingstocks.com BloggingStocks http://www.blogsmithmedia.com/http://www.bloggingstocks.com/media/feedlogo.gif BloggingStocks http://www.bloggingstocks.com en-us Copyright 2012 Weblogs, Inc. The contents of this feed are available for non-commercial use only. Blogsmith http://www.blogsmith.com/<![CDATA[You can profit from James Altucher's insanity]]>http://www.bloggingstocks.com/2009/12/12/you-can-profit-from-james-altuchers-insanity/http://www.bloggingstocks.com/2009/12/12/you-can-profit-from-james-altuchers-insanity/http://www.bloggingstocks.com/2009/12/12/you-can-profit-from-james-altuchers-insanity/#commentsFiled under: , , , ,

James Altucher is a financial journalist for The Wall Street Journal and founder of Stockpickr.com. His articles cover every angle of the market; he also stars in feature videos with other financial luminaries. He is the author of Trade Like a Hedge Fund, Trade Like Warren Buffett, SuperCa$h, and The Forever Portfolio.

He has taken a controversial path lately with numerous articles in the New York Post and Huffington Post. Some articles include: "Global Warming Is a Myth," "Should Insider Trading Be Made Legal?" "School of Hard Cash," "The Internet Is Dead (as an Investment)," and "5 Myths the Recession Taught Us."

Rumors of a new addition to the James Altucher library have entered the blogosphere, so I met with James to discuss a possible new book and the response from his recent aggressive views on finance and the stock market.

Continue reading You can profit from James Altucher's insanity

You can profit from James Altucher's insanity originally appeared on BloggingStocks on Sat, 12 Dec 2009 16:10:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>Amazon.comAMZNAOLCamecocapitalismCCJclimate changeDailyFinanceday tradingFacebookForever PortfolioFred WilsonGlaxoSmithKlineglobal warmingGOOGGoogleGSKhedge fundsHuffington Postinsider tradinginstitutional investingJames AltucherMicrosoftMSFTnaked short sellingnaked shortingNew York PostNews Corp. NWSPCLNPricelinerecessionSanofiAventisSNYswine fluTime WarnerTrade Like a Hedge FundTrade Like Warren BuffettTwitterTWXSat, 12 Dec 2009 16:10:00 EST<![CDATA[Merck (MRK) issues recall for childhood vaccines]]>http://www.bloggingstocks.com/2007/12/13/merck-mrk-issues-recall-for-childhood-vaccines/http://www.bloggingstocks.com/2007/12/13/merck-mrk-issues-recall-for-childhood-vaccines/http://www.bloggingstocks.com/2007/12/13/merck-mrk-issues-recall-for-childhood-vaccines/#commentsFiled under: , , , ,

Drug maker Merck & Co. (NYSE : MRK) announced yesterday that it had recalled slightly over one million doses [subscription required] of its childhood vaccine Hib.

For parents out there, this recall, at this time, appears to be more proactive than anything else. According to Merck, the company decided to recall approximately 1.2 million doses of the popular childhood vaccine after it discovered that the equipment used to make the vaccine had been contaminated with bacteria.

For those of you who are not familiar with the Hib vaccine, it is used to vaccinate children against meningitis, pneumonia and other serious illnesses.

Continue reading Merck (MRK) issues recall for childhood vaccines

Merck (MRK) issues recall for childhood vaccines originally appeared on BloggingStocks on Thu, 13 Dec 2007 13:22:00 EST. Please see our terms for use of feeds.

Read | Permalink | Email this | Comments]]>drugsHibinthenewsMerckMRKrecallsSanofi AventisSanofiAventisSNYvaccinesThu, 13 Dec 2007 13:22:00 EST